Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis
Selene E. Di Carlo(Inserm), Lucie Peduto(Inserm), Rachel Legendre(Institut Pasteur), Merle Stein(Universität Ulm), David Cabrerizo Granados(Inserm), Jérôme Raffenne(Inserm), Corinne Bousquet(Centre National de la Recherche Scientifique), Jan Tuckermann(Universität Ulm), A Ode(Charité - Universitätsmedizin Berlin), Hugo Varet(Institut Pasteur)
Cited by 46
Related Papers
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390
Autoregulation of pituitary corticotroph SOCS-3 expression: Characterization of the murine SOCS-3 promoter
|Proceedings of the National Academy of Sciences|1999|290
Inter‐ and intra‐tumoural heterogeneity in cancer‐associated fibroblasts of human pancreatic ductal adenocarcinoma
|The Journal of Pathology|2018|284